Long-Lasting Partial Regression of Glioblastoma Multiforme Achieved by Edotecarin: Case Report

[摘要] We describe the response to a new chemotherapy agent, topoisomerase I inhibitor edotecarin in an 18-year-old woman with recurring glioblastoma. The therapy was administered for 17 months. The radiological partial response and clinical...

[学科分类] 卫生学

[关键词] edotecarin;glioblastoma multiforme